Japan's Taisho ends year with sales down 2.1%

17 May 2019 - Deborah Wilkes

Japan's Taisho Pharmaceutical reported Self-Medication sales down by 2.1% in the 12 months ended 31 March 2019, as it prepares to acquire Bristol-Myers Squibb's French consumer healthcare business UPSA.